Two Sigma Securities’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$348K Sell
725
-632
-47% -$324K 0.04% 677
2025
Q4
$762K Buy
+1,357
New +$770K 0.1% 253
2025
Q2
Sell
-2,498
Closed -$761K 1848
2025
Q1
$761K Buy
2,498
+1,870
+298% +$629K 0.12% 219
2024
Q4
$209K Sell
628
-518
-45% -$176K 0.03% 960
2024
Q3
$383K Buy
1,146
+611
+114% +$232K 0.01% 1540
2024
Q2
$220K Sell
535
-39
-7% -$15.4K ﹤0.01% 2275
2024
Q1
$232K Sell
574
-466
-45% -$164K ﹤0.01% 2204
2023
Q4
$319K Buy
1,040
+147
+16% +$39.7K ﹤0.01% 1945
2023
Q3
$216K Buy
+893
New +$228K ﹤0.01% 2258
2022
Q3
Sell
-2,241
Closed -$335K 2900
2022
Q2
$335K Buy
+2,241
New +$324K 0.01% 1207

Other funds holding MEDP

Two Sigma Securities's MEDP Position: Q1 2026 in Review

Two Sigma Securities reduced its Medpace (MEDP) stake by 47% in Q1 2026, selling an estimated $324K and leaving 725 shares worth $348K. The position accounts for 0.04% of the portfolio, ranked #677.

Two Sigma Securities first reported a position in MEDP in Q2 2022 and has held it in 10 quarters since. The position peaked at $762K in Q4 2025. 730 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Two Sigma Securities held 725 shares of Medpace worth $348K as of Q1 2026.
  • Two Sigma Securities sold 632 Medpace shares in Q1 2026, an estimated $324K.
  • Medpace made up 0.04% of Two Sigma Securities's portfolio in Q1 2026, its #677 holding.
  • Two Sigma Securities first reported a position in Medpace in Q2 2022 and has held it in 10 quarters since.
  • Two Sigma Securities's Medpace position peaked at $762K in Q4 2025.
  • 730 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.